Supernus Pharmaceuticals (SUPN) Prepaid Assets (2011 - 2026)
Supernus Pharmaceuticals (SUPN) reported Prepaid Assets of $78.1 million for Q1 2026, up 169.93% year-over-year from $28.9 million in Q1 2025, and up 19.55% quarter-over-quarter from $65.3 million in Q4 2025.
Supernus Pharmaceuticals (SUPN) Prepaid Assets (2011 - 2026) Analysis & Trends
Supernus Pharmaceuticals (SUPN) has 16 years of Prepaid Assets data on file, last reported at $78.1 million in Q1 2026.
- Prepaid Assets for Q1 2026 came in at $78.1 million, up 169.93% year-over-year; the trailing twelve-month figure through Mar 2026 was $78.1 million (up 169.93% YoY), and the FY2025 annual result was $65.3 million, up 81.02% from the prior year.
- Prepaid Assets grew to $78.1 million in Q1 2026 per SUPN's latest filing, from $65.3 million in the prior quarter.
- Over five years, Prepaid Assets peaked at $78.1 million in Q1 2026 and troughed at $15.8 million in Q4 2022.
- A 5-year average of $33.1 million and a median of $24.8 million in 2022 frame the typical range for Prepaid Assets.
- The sharpest annual moves came in 2024 and 2026: Prepaid Assets plunged 48.25% in 2024, then jumped 169.93% in 2026.
- A 5-year view of Prepaid Assets shows it stood at $15.8 million in 2022, then grew by 5.68% to $16.7 million in 2023, then soared by 116.41% to $36.1 million in 2024, then jumped by 81.02% to $65.3 million in 2025, then climbed by 19.55% to $78.1 million in 2026.
- Business Quant data shows SUPN's Prepaid Assets at $78.1 million in Q1 2026, $65.3 million in Q4 2025, and $62.1 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn |
| 10 | Supernus Pharmaceuticals | 2.63 Bn | 2.24 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 78.09 Mn |
| Dec 31, 2025 | 65.33 Mn |
| Sep 30, 2025 | 62.08 Mn |
| Jun 30, 2025 | 31.42 Mn |
| Mar 31, 2025 | 28.93 Mn |
| Dec 31, 2024 | 36.09 Mn |
| Sep 30, 2024 | 27.40 Mn |
| Jun 30, 2024 | 23.17 Mn |
| Mar 31, 2024 | 23.77 Mn |
| Dec 31, 2023 | 16.68 Mn |
| Sep 30, 2023 | 23.93 Mn |
| Jun 30, 2023 | 44.77 Mn |
| Mar 31, 2023 | 16.30 Mn |
| Dec 31, 2022 | 15.78 Mn |
| Sep 30, 2022 | 24.85 Mn |
| Jun 30, 2022 | 21.41 Mn |
| Mar 31, 2022 | 22.37 Mn |
| Dec 31, 2021 | 27.02 Mn |
| Sep 30, 2021 | 30.69 Mn |
| Jun 30, 2021 | 33.74 Mn |